Tilogotamab is an enhanced agonistic formulation composed of two antibodies, each targeting distinct epitopes on death receptor type 5 (DR5). This specific interaction with DR5 facilitates its activation, making Tilogotamab a valuable tool in the study of multiple myeloma (MM). This product is designed for research use, focusing on elucidating the pathways and mechanisms associated with DR5 in multiple myeloma.
Tilogotamab is an enhanced agonistic formulation composed of two antibodies, each targeting distinct epitopes on death receptor type 5 (DR5). This specific interaction with DR5 facilitates its activation, making Tilogotamab a valuable tool in the study of multiple myeloma (MM). This product is designed for research use, focusing on elucidating the pathways and mechanisms associated with DR5 in multiple myeloma.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
